期刊文献+

抗癌药紫杉醇及其衍生物多西他赛药理及毒理性质的密度泛函研究 被引量:4

Density Functional Theory Study on Pharmacology and Toxicology of Taxol and Its Derivative Docetaxel
下载PDF
导出
摘要 采用密度泛函理论B3LYP方法在STO-3G基组上对抗癌药紫杉醇和多西紫杉醇分子进行优化并进行理论计算,对它们的分子构型、偶极距、红外光谱(IR)、紫外光谱(UV-Vis)、NBO电荷分布进行了分析。结果表明,紫杉醇和多西紫杉醇发挥其药理和毒理作用的最大可能部位在酰胺基的N原子上。 Using the density functional theory B3LYP method with STO-3G basis set, molecules of taxol and docetaxel were optimized, and the theoretical calculation was carried out; their molecular dipole moment and configuration, IR spectra, UV spectra, NBO charge distribution were analyzed. The results show that, the maximum possible parts of pharmacological and toxicological effects of taxol and docetaxel are their N atoms on the amide.
出处 《当代化工》 CAS 2015年第4期684-686,690,共4页 Contemporary Chemical Industry
基金 浙江省大学生科技创新项目(新苗人才计划) 项目号:2014R428015
关键词 紫杉醇 多西紫杉醇 密度泛函 量化计算 Taxol Docetaxel Density functional theory Quantitative calculation
  • 相关文献

参考文献6

二级参考文献17

  • 1陈晓萍,薛兴奎,张沂平,宋恕平,宋现让,盛立军,马胜林,王泽时.多西紫杉醇对胃癌细胞作用及其机制的研究[J].肿瘤,2006,26(4):343-345. 被引量:9
  • 2周永洽,太俊哲,梁宏,欧阳砥,刘宏,胡绪英,黄杰生.金属-血清白蛋白的结构研究(Ⅸ)──Ni(Ⅱ)-HSA和Ni(Ⅱ)-BSA的新型减色效应[J].高等学校化学学报,1996,17(9):1331-1335. 被引量:5
  • 3SJOSTROM J,BIOMQVIST C,yon BOGUSLAWSKI K,et al.The predictive value of bcl-2,bax,bcl-xL,bag-1,fas,and fasL for chemotherapy response in advanced breast cancer[J].Clin Cancer Res,2002,8(3):811-816. 被引量:1
  • 4GREENLEE RT,HILL-HARMON MB,MURRAYT.Cancer statistics[J].CA Cancer J Clin,2001,51 (1):15-36. 被引量:1
  • 5VASSILOMANOLAKIS M,KOUMAKIS G,BARBOUNIS V,et al.First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer[J].Breast,2005,14(2):136-141. 被引量:1
  • 6GIANNAKAKOU P,VILLALBA L,LI H,et al.Combinationsof paclitaxel and vinblastine and their effects on tubulin polim erization and cytotoxicity:characterization of a synergistic schedule[J].Int J Cancer,1998,75 (1):57-63. 被引量:1
  • 7EISENHAUER EA,VERMORKEN J B.Comparativc clinical pharmacology and therapeutic potential[J].Drugs,1998,55 (1):5-30. 被引量:1
  • 8MOTWANI M,RIZZO C,SIROTNAK F,et al.Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells[J].Mol Cancer Ther,2003,2 (6):549-555. 被引量:1
  • 9ZHAO J,KIM J E,REED E,et al.Molecular mechanism of antitumor activity of taxanes in lung cancer[J].Int J Oncol,2005,27(1):247-56. 被引量:1
  • 10曾益新,吕有勇,朱明华,等.肿瘤学[M].2版.北京:人民卫生出版社,2002:222-226. 被引量:1

共引文献39

同被引文献54

  • 1Vargesson N.Thalidomide-induced teratogenesis:History and mechanisms[J].Birth Defects Res C Embryo Today,2015,105(2):140-156. 被引量:1
  • 2Feldschreiber P,Breckenridge A.After thalidomide-do we have the right balance between public health and intellectual property[J]. Rev Recent Clin Trials,2015,10(1):15-18. 被引量:1
  • 3Yang C,Singh P,Singh H,et al.Systematic review:thalidomide and thalidomide analogues for treatment of inflammatory bowel disease [J].Aliment Pharmacol Ther,2015,41(11):1079-1093. 被引量:1
  • 4Yang CS,Kim C,Antaya FU.Review of thalidomide use in the pediatric population[J].J Am Acad Dermatol,2015,72(4):703-711. 被引量:1
  • 5Koeppen S.Treatment of multiple myeloma:thalidomide,bortezomib and lenalidomide induced peripheral neuropathy[J].Oncol Res Treat,2014,37(9):506-513. 被引量:1
  • 6Galustian C,Dalgleish A.Lenalidomide;a novel anticancer drug with multiple modalities[J].Expert Opin Pharmacother,2009,10(1);125-133. 被引量:1
  • 7NCCN Guidelines for Treatment of Cancer by Site-Non Small Cell Lung Cancer[EB/OL].National Comprehensive Cancer Network.2015,20th Annual Edition,[2015-06-01].http://www. nccn.org/professionals/physician_ gls/f_ guidelines.asp#nscl. 被引量:1
  • 8Higgins JP,Green S.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[EB/OL].(2011-03)[2015-06-01].http://handbook,cochrane.org/. 被引量:1
  • 9Hoang T,Dahlberg SE,Schiller JH,et al.Randomized phase Ⅲ study of thoracic radiation in combination with paclitaxel and carbopiatin with or without thalidomide in patients with stage Ⅲ non- small-cell lung cancer:the ECOG 3598 Study[J].J Clin Oncol,2012,30(6):616-622. 被引量:1
  • 10Yu J,Liu F,Sun Z,et al.The enhancement of radiosensitivity in human esophageal carcinoma cells by thalidomide and its potential mechanism[J].Cancer Biother Radiopharm,2011,26(2):219-227. 被引量:1

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部